Login / Signup

Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients.

Lucas M BryantKelly E DanielsDavid M CognettiPatrick T TassoneAdam J LuginbuhlJoseph M Curry
Published in: Laryngoscope investigative otolaryngology (2018)
ESS modulators may play both a causal and therapeutic role in several disorders seen in otolaryngology patients. The use of cannabis and cannabinoids is not without risk. There is a need for further research to better understand both the adverse and therapeutic effects of cannabis use. With increasing rates of consumption, elevated public awareness, and rapidly changing legislation, it is helpful for the otolaryngologist to be aware of both the adverse manifestations of use and the potential therapeutic benefits when talking with patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • healthcare
  • emergency department
  • mental health
  • patient reported outcomes
  • adverse drug